Michael Halstead
CIK: 0001521548
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Sep 21, 2026CYBN
CYBIN INC.
Purchase(P)Direct100K shares at avg. $13.47$1.3M - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
Award(A)DirectPerformance Stock Units
13.1K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
Disposition(D)Direct21.3K shares at avg. $132.00$2.8M - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
Award(A)DirectPerformance Stock Units
12.2K shares- - Mar 10, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax Payment(F)Direct3.8K shares at avg. $131.24$493K - Mar 10, 2025ITCI
Intra-Cellular Therapies, Inc.
Exercise(M)Direct7.3K shares- - Mar 6, 2025ITCI
Intra-Cellular Therapies, Inc.
Exercise(M)Direct13.1K shares- - Mar 6, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax Payment(F)Direct6.7K shares at avg. $131.19$881K - Mar 1, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax Payment(F)Direct6.3K shares at avg. $128.20$803K - Mar 1, 2025ITCI
Intra-Cellular Therapies, Inc.
Exercise(M)Direct12.2K shares- - Feb 3, 2025ITCI
Intra-Cellular Therapies, Inc.
Award(A)DirectRestricted Stock Units
45.5K shares- - Jan 31, 2025ITCI
Intra-Cellular Therapies, Inc.
Award(A)Direct11K shares- - Jan 31, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax Payment(F)Direct5.7K shares at avg. $127.00$723K - Nov 13, 2024ITCI
Intra-Cellular Therapies, Inc.
Sale(S)Direct13.4K shares at avg. $88.17$1.2M - Nov 13, 2024ITCI
Intra-Cellular Therapies, Inc.
Sale(S)Direct5.3K shares at avg. $88.92$475K - Nov 13, 2024ITCI
Intra-Cellular Therapies, Inc.
Exercise(M)Direct18.7K shares at avg. $36.89$690K - Nov 12, 2024ITCI
Intra-Cellular Therapies, Inc.
Sale(S)Direct15.1K shares at avg. $88.72$1.3M - Nov 12, 2024ITCI
Intra-Cellular Therapies, Inc.
Exercise(M)Direct22.9K shares at avg. $23.94$547K - Nov 12, 2024ITCI
Intra-Cellular Therapies, Inc.
Sale(S)Direct6.1K shares at avg. $89.63$548K - Nov 12, 2024ITCI
Intra-Cellular Therapies, Inc.
Sale(S)Direct1.6K shares at avg. $90.89$150K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 |  CYBN CYBIN INC. | Purchase(P) | 100,000 | $13.47 | $1,347,050 | Direct |
| Apr 2, 2025 |  ITCI Intra-Cellular Therapies, Inc. | Award(A) Performance Stock Units | 13,134 | - | - | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Disposition(D) | 21,307 | $132.00 | $2,812,524 | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award(A) Performance Stock Units | 12,240 | - | - | Direct |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment(F) | 3,757 | $131.24 | $493,069 | Direct |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise(M) | 7,345 | - | - | Direct |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise(M) | 13,133 | - | - | Direct |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment(F) | 6,718 | $131.19 | $881,334 | Direct |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment(F) | 6,261 | $128.20 | $802,660 | Direct |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise(M) | 12,239 | - | - | Direct |
| Feb 3, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award(A) Restricted Stock Units | 45,454 | - | - | Direct |
| Jan 31, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award(A) | 11,017 | - | - | Direct |
| Jan 31, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment(F) | 5,691 | $127.00 | $722,757 | Direct |
| Nov 13, 2024 | ITCI Intra-Cellular Therapies, Inc. | Sale(S) | 13,371 | $88.17 | $1,178,921 | Direct |
| Nov 13, 2024 | ITCI Intra-Cellular Therapies, Inc. | Sale(S) | 5,343 | $88.92 | $475,100 | Direct |
| Nov 13, 2024 | ITCI Intra-Cellular Therapies, Inc. | Exercise(M) | 18,714 | $36.89 | $690,359 | Direct |
| Nov 12, 2024 | ITCI Intra-Cellular Therapies, Inc. | Sale(S) | 15,105 | $88.72 | $1,340,116 | Direct |
| Nov 12, 2024 | ITCI Intra-Cellular Therapies, Inc. | Exercise(M) | 22,869 | $23.94 | $547,484 | Direct |
| Nov 12, 2024 | ITCI Intra-Cellular Therapies, Inc. | Sale(S) | 6,116 | $89.63 | $548,177 | Direct |
| Nov 12, 2024 | ITCI Intra-Cellular Therapies, Inc. | Sale(S) | 1,648 | $90.89 | $149,787 | Direct |
1-20 of 20 transactions
About Halstead Michael
Halstead Michael (SEC CIK 0001521548) files insider reports with the SEC as Chief Executive Officer of CYBIN INC. (CYBN) and President of Intra-Cellular Therapies, Inc. (ITCI).
Signal8 holds 7 ownership filings by Halstead Michael (1 Form 3, 6 Form 4), filed between Nov 14, 2024 and Sep 21, 2026. Those filings report 20 transactions, from Nov 12, 2024 to Sep 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Halstead Michael's filings is in TORONTO.
Recent filings by Halstead Michael
- Sep 21, 2026: Open-market purchase of CYBN shares (Form 4, code P).
- Apr 2, 2025: Grant or award of ITCI derivative securities (Form 4, code A).
- Apr 2, 2025: Disposition to issuer transaction of ITCI shares (Form 4, code D).
- Apr 2, 2025: Grant or award of ITCI derivative securities (Form 4, code A).
- Mar 10, 2025: Tax withholding of ITCI shares (Form 4, code F).